37 related articles for article (PubMed ID: 12808303)
1. Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses.
Davis JL; Kruger K; LaFevers DH; Barlow BM; Schirmer JM; Breuhaus BA
Equine Vet J; 2014 Nov; 46(6):729-33. PubMed ID: 24175935
[TBL] [Abstract][Full Text] [Related]
2. Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency.
Verpooten GA; Genissel PM; Thomas JR; De Broe ME
Br J Clin Pharmacol; 1991 Aug; 32(2):187-92. PubMed ID: 1657092
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of quinapril and its active metabolite, quinaprilat, in patients on chronic hemodialysis.
Blum RA; Olson SC; Kohli RK; Horvath AM; Sedman AJ; Posvar EL
J Clin Pharmacol; 1990 Oct; 30(10):938-42. PubMed ID: 2229454
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of quinaprilat after low dose quinapril in patients with terminal renal failure.
Wolter K; Fritschka E
Eur J Clin Pharmacol; 1993; 44 Suppl 1():S53-6. PubMed ID: 8387427
[TBL] [Abstract][Full Text] [Related]
5. Clearance of imidapril, an Angiotensin-converting enzyme inhibitor, during hemodialysis in hypertensive renal failure patients: comparison with quinapril and enalapril.
Tsuruoka S; Kitoh Y; Kawaguchi A; Sugimoto K; Hayasaka T; Saito T; Fujimura A
J Clin Pharmacol; 2007 Feb; 47(2):259-63. PubMed ID: 17244777
[TBL] [Abstract][Full Text] [Related]
6. Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis.
Yamada S; Muraoka I; Kato K; Hiromi Y; Takasu R; Seno H; Kawahara H; Nabeshima T
Biol Pharm Bull; 2003 Jun; 26(6):872-5. PubMed ID: 12808303
[TBL] [Abstract][Full Text] [Related]
7. Quinapril: a new second-generation ACE inhibitor.
Cetnarowski-Cropp AB
DICP; 1991 May; 25(5):499-504. PubMed ID: 2068835
[TBL] [Abstract][Full Text] [Related]
8. Quinaprilat: a review of its pharmacokinetics, pharmacodynamics, toxicological data and clinical application.
Kieback AG; Felix SB; Reffelmann T
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1337-47. PubMed ID: 19761414
[TBL] [Abstract][Full Text] [Related]
9. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure.
Hoyer J; Schulte KL; Lenz T
Clin Pharmacokinet; 1993 Mar; 24(3):230-54. PubMed ID: 8462229
[TBL] [Abstract][Full Text] [Related]
11. Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology.
Kaplan HR; Taylor DG; Olson SC; Andrews LK
Angiology; 1989 Apr; 40(4 Pt 2):335-50. PubMed ID: 2539761
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of captopril, enalapril, and quinapril.
Vertes V; Haynie R
Am J Cardiol; 1992 Apr; 69(10):8C-16C. PubMed ID: 1546641
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
